Which of the following is a component of the Khorana score that has been validated as a risk factor for the development of venous thromboembolism (VTE) in a patient receiving chemotherapy?
A. Age >55 Wrong Choice!
B. Body mass index (BMI) >30 Wrong Choice!
C. Prechemotherapy platelet count >350 × 109 /L Correct Choice
D. Thyroid cancer Wrong Choice!
Answer:C
Which of the following is a component of the Khorana score that has been validated as a risk factor for the development of venous thromboembolism (VTE) in a patient receiving chemotherapy?
A. Age >55 Wrong Choice! B. Body mass index (BMI) >30 Wrong Choice! C. Prechemotherapy platelet count >350 × 109 /L Correct Choice D. Thyroid cancer Wrong Choice!